← Open Payments lookup

ERIN DOHLMAN: Open Payments

NPI 1578121075 · URBANDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,585 in 88 payments from 20 companies in 2025. Trend: 2023 $1,132 · 2024 $1,446 · 2025 $1,585

Food & beverage: $1,567Education: $19
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$279
PFIZER INC.17$272
ABBVIE INC.10$163
Boehringer Ingelheim Pharmaceuticals, Inc.9$135
Novo Nordisk Inc5$110
Phathom Pharmaceuticals, Inc.7$90
Bayer Healthcare Pharmaceuticals Inc.4$82
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Lundbeck LLC3$58

Products named: FARXIGA, JARDIANCE, NURTEC ODT, REXULTI, VOQUEZNA, UBRELVY, Kerendia, ELIQUIS.

Industry payments across IA — which companies pay providers there.